Europe's pharmaceutical industry presents a complex landscape rife with both challenges. Regulators across the continent are increasingly demanding stringent regulations while patients seek accessible treatments. This transformative environment necessitates a tactical approach for pharmaceutical companies looking to succeed. Stakeholders must metic